Intensity Therapeutics earnings were -$11.6M for the trailing 12 months ending Dec 31, 2025, with N/A growth year over year. The latest INTS earnings report on Dec 31, 2025 announced Q4 2025 earnings of -$3.1M, up 14.2% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, INTS reported annual earnings of -$11.6M, with -28.7% growth. The next INTS earnings date is May 7, 2026.
Intensity Therapeutics Earnings Reports & History FAQ
What were Intensity Therapeutics's earnings last quarter?
On INTS's earnings call on Invalid Date, Intensity Therapeutics (NASDAQ: INTS) reported Q4 2025 earnings per share (EPS) of -$0.36, up 93.38% year over year. Total INTS earnings for the quarter were -$3.05 million. In the same quarter last year, Intensity Therapeutics's earnings per share (EPS) was -$5.44.
The next INTS earnings call is Invalid Date. Add INTS to your watchlist to be reminded of Intensity Therapeutics's next earnings date.
Is Intensity Therapeutics profitable or losing money?
As of the last Intensity Therapeutics earnings report, Intensity Therapeutics is currently losing money. Intensity Therapeutics's net profit (also called net income) for the twelve months ending Dec 31, 2025 was -$11.61 million, a 28.66% decrease year over year.
What was INTS's earnings growth in the past year?
As of Intensity Therapeutics's earnings date in Invalid Date, Intensity Therapeutics's earnings has grown year over year. INTS earnings in the past year totalled -$11.61 million.
What are Intensity Therapeutics's earnings expectations?
The current EPS estimate for Intensity Therapeutics's earnings report in Invalid Date is -$0.06.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.